170.30 -10.30 (-5.70%)

New 52W Low today

63,805 NSE+BSE Volume

BSE 25 Mar, 2025 3:31 PM (IST)



Board Meetings - Natural Capsules Ltd.

The latest board meeting for Natural Capsules Ltd. took place on 12 Feb 2025, for the purpose of Quarterly Results

Ex-date Purpose Notes
12 Feb 2025 Quarterly Results -
12 Nov 2024 Quarterly Results -
13 Aug 2024 Quarterly Results -
26 Jul 2024 Preferential issue of shares Inter alia, to consider and approve the proposal for raising funds by way of issue of Equity Shares through Preferential Issue, Private Placements or combination thereof.
21 May 2024 Audited Results & Dividend -
09 Feb 2024 Quarterly Results -
09 Nov 2023 Quarterly Results -
09 Aug 2023 Quarterly Results -
26 May 2023 Audited Results & Final Dividend -
13 Feb 2023 Quarterly Results -
28 Oct 2022 Quarterly Results & Others Inter alia, To discuss on making further call on balance right issue money;
10 Aug 2022 Quarterly Results -
09 May 2022 Audited Results, Dividend & Rights issue -
08 Feb 2022 Quarterly Results (Revised)
28 Dec 2021 Rights Issue -
30 Oct 2021 Quarterly Results & Rights issue -
07 Aug 2021 Quarterly Results & Right issue -
31 May 2021 Audited Results, Dividend & Rights issue -
25 Jan 2021 Quarterly Results -
07 Nov 2020 Quarterly Results -
07 Aug 2020 Quarterly Results -
05 Jun 2020 Audited Results & Dividend -
08 Feb 2020 Quarterly Results -
12 Nov 2019 Quarterly Results & Others -
09 Aug 2019 Quarterly Results -
30 May 2019 Audited Results & Dividend -
09 Feb 2019 Quarterly Results -
10 Nov 2018 Quarterly Results -
30 Jul 2018 Quarterly Results & Others -
18 May 2018 Audited Results & Dividend -
29 Jan 2018 Quarterly Results -
04 Nov 2017 Quarterly Results -
09 Aug 2017 Quarterly Results -
27 May 2017 Audited Results -
31 Jan 2017 Quarterly Results -
27 Oct 2016 Quarterly Results -
26 Aug 2016 Preferential Issue of shares -
30 Jul 2016 Quarterly Results Approval of the Directors Report for the financial year 2015-16.
28 May 2016 Audited Results & Dividend -
27 Jan 2016 Quarterly Results & Others To consider and approve Listing agreement between BSE limited and NCL as per Annexure I of SEBI (listing obligation and Disclosure requirement) Regulations, 2015.
29 Oct 2015 Quarterly Results To consider and analyse the current business activities of M/s. Supreem Pharmaceuticals Mysore Pvt. Ltd.
09 Sep 2015 Allotment of Equity Shares The Board has approved and allotted the equity shares & Convertible Securities (Equity share warrants) to promoters and investors.
14 Aug 2015 Others 1. To consider and approve the pending share warrant conversion to equity share allotment to promoters (preferential issue). 2. To consider the current status of investment in a pharmaceutical comp.
29 Jul 2015 Preferential Allotment of shares -
30 May 2015 Audited Results & Dividend -
26 Mar 2015 Others Appointment of Mrs. Jyothi Mundra, as Woman Director of company
10 Feb 2015 To Consider Allotment of Equity Shares To consider allotment of 2,20,000 Equity Shares of Rs. 10/- each on conversion of warrants issued as per the terms approved by the Members in the EGM held on February 20, 2014.
29 Jan 2015 Quarterly Results -
25 Jan 2014 Others To consider preferential Allotment of shares to promoters and their associates.
30 Oct 2013 Quarterly Results -
25 Jul 2013 Quarterly Results -
25 May 2013 Audited Results -
21 Jan 2013 Quarterly Results -
26 Jul 2012 Quarterly Results -
26 May 2012 Audited Results & Dividend -
30 Jan 2012 Quarterly Results -
22 Oct 2011 Quarterly Results -
28 May 2011 Audited Results & Dividend -
28 Jan 2011 Quarterly Results -
23 Oct 2010 Quarterly Results -
30 Jul 2010 Quarterly Results -
22 May 2010 Audited Results -
23 Jan 2010 Quarterly Results -
26 Oct 2009 Quarterly Results -
30 Jul 2009 Quarterly Results -
30 Jan 2009 Others To consider receipt of letters from allottees of the share warrants, who have express their inability to exercise the option of converting 4,80,000 allotted share warrants to equity shares.
25 Oct 2008 Quarterly Results -
30 Jul 2008 Quarterly Results -
30 May 2008 Audited Results & Dividend -
14 Mar 2008 Allotment of Equity Shares/Warrants To consider allotment of Equity Shares / Share Warrants of Rs 10/- each at the premium rate of Rs 30/- to the promoters and their associates on preferential basis.
31 Jan 2008 Quarterly Results & Others to consider preferential allotment of equity shares to promoters and their associates.
06 Oct 2007 Quarterly Results -
26 Jul 2007 Quarterly Results -
29 May 2007 Audited Results & Dividend -
28 Jul 2006 Quarterly Results -
29 May 2006 Accounts & Dividend -
28 Jan 2006 Quarterly Results -
22 Oct 2005 Quarterly Results -
29 Jul 2005 Quarterly Results -
26 May 2005 Dividend -
29 Jan 2005 Quarterly Results -
29 Nov 2004 Others Allotted to investors total of 8,08,000 equity shares of face value of Rs.10/- each at a price of Rs.30/- per equity shares(including share premium of Rs.20/- per share)
20 Oct 2004 Preferential Issue of shares To consider additional business of issue of preferential allottment of equity shares to promoters and others.
23 Jul 2004 Quarterly Results -
28 Apr 2004 Accounts -
29 Oct 2003 Quarterly Results -
26 Jul 2003 Quarterly Results -
25 Jan 2003 Quarterly Results -
28 Oct 2002 Quarterly Results -
26 Jul 2002 Quarterly Results -
25 May 2002 Accounts -
28 Jul 2001 Quarterly Results -
26 May 2001 Accounts -
31 Jan 2001 Quarterly Results -
27 May 2000 Accounts -
29 Jan 2000 Quarterly Results -
25 Oct 1999 Quarterly Results -
23 Feb 1998 Half Yearly Results -